World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
49
Citations
9485
World Ranking
4332
National Ranking
288

Overview

Jan D. Lünemann is a researcher affiliated with the University Hospital of Münster in Germany focusing on medicine, immunology, and neurology. Their work spans multiple subfields, including neurology, immunology, pathology and forensic medicine, molecular biology, and oncology.

Their research covers a range of topics primarily centered on neurological and immunological disorders. Main themes include multiple sclerosis research studies, peripheral neuropathies and disorders, myasthenia gravis and thymoma, T-cell and B-cell immunology, immune cell function and interaction, neuroinflammation and neurodegeneration mechanisms, and immunotherapy and immune responses.

Recent publications by Jan D. Lünemann include:

  • Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study (2023) in The Lancet Neurology
  • Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper) (2021) in Therapeutic Advances in Neurological Disorders
  • Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis (2021) in Neurology Neuroimmunology & Neuroinflammation
  • NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients (2020) in Brain
  • International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis (2024) in Autophagy

Lünemann has frequently published in the following venues:

  • Neurology Neuroimmunology & Neuroinflammation (11 publications)
  • Annals of Neurology (5 publications)
  • Frontiers in Immunology (5 publications)
  • Brain (4 publications)
  • Autophagy (4 publications)

Collaborations form an important part of their research activity. Frequent co-authors include Heinz Wiendl, Christian W. Keller, Luisa Klotz, Xavier Montalbán, and Catharina C. Groß.

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

    Daniel J. Klionsky;Amal Kamal Abdel-Aziz;Sara Abdelfatah;Mahmoud Abdellatif

  • Antiviral immune responses: triggers of or triggered by autoimmunity?

    Christian Münz;Jan D. Lünemann;Meghann Teague Getts;Stephen D. Miller

  • EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-γ and IL-2

    Jan D. Lünemann;Ilijas Jelčić;Susanne Roberts;Andreas Lutterotti

  • Intravenous immunoglobulin in neurology—mode of action and clinical efficacy

    Jan D. Lünemann;Falk Nimmerjahn;Marinos C. Dalakas

  • Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity

    Isaak Quast;Christian W. Keller;Michael A. Maurer;John P. Giddens

  • Elevated Epstein–Barr virus‐encoded nuclear antigen‐1 immune responses predict conversion to multiple sclerosis

    Jan D. Lünemann;Mar Tintoré;Brady Messmer;Brady Messmer;Till Strowig

  • Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

    Björn Tackenberg;Ilijas Jelčić;Anne Baerenwaldt;Wolfgang H. Oertel

  • Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.

    Jan D. Lünemann;Nancy Edwards;Paolo A. Muraro;Shuhei Hayashi

  • TNF-related apoptosis inducing ligand (TRAIL) as a potential response marker for interferon-beta treatment in multiple sclerosis

    Klaus-Peter Wandinger;Jan D Lünemann;Oliver Wengert;Judith Bellmann-Strobl

  • A type I interferon signature in monocytes is associated with poor response to interferon-β in multiple sclerosis

    M. Comabella;J. D. Lünemann;J. Río;A. Sánchez

  • Fc-Galactosylation of Human Immunoglobulin Gamma Isotypes Improves C1q Binding and Enhances Complement-Dependent Cytotoxicity

    Unknown

  • Infectious causes of multiple sclerosis

    Gavin Giovannoni;Gary R Cutter;Jan Lunemann;Roland Martin

  • Viral triggers of multiple sclerosis

    Kristina Kakalacheva;Christian Münz;Jan D. Lünemann

  • Death Ligand TRAIL Induces No Apoptosis but Inhibits Activation of Human (Auto)antigen-Specific T Cells

    Jan D. Lünemann;Sonia Waiczies;Stefan Ehrlich;Uwe Wendling

  • Regulatory NK-cell functions in inflammation and autoimmunity.

    Anna Lünemann;Jan D. Lünemann;Christian Münz

  • Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop.

    Maria Pia Amato;Tobias Derfuss;Bernard Hemmer;Roland Liblau

  • Epstein-Barr Virus: Environmental Trigger of Multiple Sclerosis?

    Jan D. Lünemann;Thomas Kamradt;Roland Martin;Christian Münz

  • β-amyloid is a substrate of autophagy in sporadic inclusion body myositis

    Jan D. Lünemann;Jens Schmidt;Dorothee Schmid;Konstanze Barthel

  • TNF-alpha induces macroautophagy and regulates MHC class II expression in human skeletal muscle cells

    Christian W. Keller;Claudia Fokken;Stuart G. Turville;Anna Lünemann;Anna Lünemann

  • NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

    Sunny Malhotra;Carme Costa;Herena Eixarch;Christian W Keller;Christian W Keller

  • Broader Epstein–Barr virus–specific T cell receptor repertoire in patients with multiple sclerosis

    Unknown

  • Epstein-Barr virus and multiple sclerosis

    Jan D. Lünemann;Christian Münz

Frequent Co-Authors

Heinz Wiendl
Heinz Wiendl University of Münster
Russell C. Dale
Russell C. Dale University of Sydney
Christian Münz
Christian Münz University of Zurich
Atanas G. Atanasov
Atanas G. Atanasov Medical University of Vienna
Tiago F. Outeiro
Tiago F. Outeiro University of Göttingen
Philippe Pierre
Philippe Pierre Aix-Marseille University
Luisa Klotz
Luisa Klotz University Hospital Münster
Catharina C. Gross
Catharina C. Gross University of Münster
Antonio Cuadrado
Antonio Cuadrado Autonomous University of Madrid
Changlian Zhu
Changlian Zhu University of Gothenburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related health science degrees can open diverse career opportunities. Nursing pathways, for example, provide a strong foundation in patient care and clinical sciences, which complement immunological expertise.

Many aspiring nurses start with the easiest absn program to get into, allowing for a quicker transition into nursing roles. Similarly, those beginning their healthcare journey might consider lpn programs easy to get into, offering practical training and a stepping stone toward advanced roles.

As professionals advance, selecting from the easiest np programs to get into ensures access to nurse practitioner education with manageable admission criteria. For specialized mental health nursing, online pmhnp programs with clinical placement opportunities are crucial, ensuring hands-on experience in psychiatric care settings.

Understanding these pathways can help Immunology students tailor their education toward impactful careers in healthcare and research. Combining Immunology with nursing credentials or mental health specialization can lead to vital roles in patient treatment, clinical trials, and public health.

Best Scientists Citing Jan D. Lünemann

Trending Scientists

Recently Published Articles